Expert In Zoloft MDL Was Properly Excluded, Judge Says
Law360, New York (January 26, 2015, 4:11 PM EST) -- A Pennsylvania federal judge Friday declined to reconsider her decision barring a plaintiffs' causation expert from multidistrict litigation against Pfizer Inc. over Zoloft’s alleged link to birth defects, saying she had properly considered the expert's methodology without overemphasizing its lack of statistically significant findings.
U.S. District Judge Cynthia M. Rufe said that her decision to exclude testimony from epidemiologist Dr. Anick Berard hadn’t relied on any bright-line rule excluding general causation experts for drawing conclusions about causation in the absence of replicated, statistically significant associations, which the plaintiffs had argued was not permitted under previous court precedent.
The plaintiffs in...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!